Skip to main content
Full access
New Research
Published Online: 1 March 2012

Association of Cerebral Emboli With Accelerated Cognitive Deterioration in Alzheimer's Disease and Vascular Dementia

This article has been corrected.
VIEW CORRECTION

Abstract

Transcranial Doppler imaging found middle cerebral artery emboli in nearly half of patients with either vascular or Alzheimer's dementia. Patients with emboli had more rapid progression of dementia over 2 years than those who were emboli free, and their declines in overall functioning and behavior were over two times as great.

Abstract

Objective:

Spontaneous cerebral emboli occur frequently in patients with Alzheimer's disease and vascular dementia. The authors investigated the effect of cerebral emboli on cognitive and functional decline in both Alzheimer's disease and vascular dementia patients over a 2-year period.

Method:

Cerebral emboli entering the middle cerebral arteries were counted at baseline and every 6 months over the following 18 months using transcranial Doppler ultrasonography in 144 patients with dementia (Alzheimer's disease, N=84; vascular dementia, N=60). Deterioration in cognition was measured every 6 months over 2 years using the Alzheimer's Disease Assessment Scale-Cognitive (ADAS-Cog), the Mini-Mental State Examination (to assess cognition), the Interview for Deterioration in Daily Living Activities in Dementia (to assess function), and the Neuropsychiatric Inventory (to assess behavioral and psychological symptoms). The relationship between cerebral emboli and progression of dementia was analyzed using longitudinal regression modeling, adjusted for age, sex, diagnostic subtype, age at onset of dementia, and significant vascular risk factors.

Results:

Spontaneous cerebral emboli were detected in 63 (44%) dementia patients, 36 (43%) Alzheimer's disease patients, and 27 (45%) vascular dementia patients. ADAS-Cog scores revealed faster deterioration in cognitive functioning in patients with cerebral emboli over 2 years, with a mean increase in score of 15.4 in these patients, compared with only 6.0 for those without cerebral emboli. Similarly, Interview for Deterioration in Daily Living Activities in Dementia scores revealed more rapid deterioration in those with cerebral emboli, with a mean increase in score of 59.0 in these patients, compared with 17.9 for those without cerebral emboli. Neuropsychiatric Inventory scores also indicated faster decline in patients with cerebral emboli, with a mean increase in score of 12.0 in these patients, compared with a mean decrease in score of –3.8 for patients in whom no emboli were detected.

Conclusions:

Spontaneous cerebral emboli predict more rapid progression of dementia over 2 years in both Alzheimer's disease and vascular dementia. Clinical trials on the inhibition of cerebral emboli in the prevention and treatment of dementia are needed.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 300 - 308
PubMed: 22193532

History

Received: 4 January 2011
Revision received: 8 July 2011
Accepted: 15 August 2011
Published online: 1 March 2012
Published in print: March 2012

Authors

Affiliations

Nitin Purandare, Ph.D., F.R.C.Psych.
From the Manchester Academic Health Science Center and Mental Health and Neurodegeneration Research Group, University of Manchester, Manchester, United Kingdom; the Mental Health and Social Care Trust, Manchester, United Kingdom; the Vascular Studies Unit and Academic Surgery Unit, University of Manchester, Manchester, United Kingdom; and the Department of Medical Statistics, University Hospital of South Manchester, Manchester, United Kingdom.
Alistair Burns, M.D., F.R.C.Psych.
From the Manchester Academic Health Science Center and Mental Health and Neurodegeneration Research Group, University of Manchester, Manchester, United Kingdom; the Mental Health and Social Care Trust, Manchester, United Kingdom; the Vascular Studies Unit and Academic Surgery Unit, University of Manchester, Manchester, United Kingdom; and the Department of Medical Statistics, University Hospital of South Manchester, Manchester, United Kingdom.
Julie Morris, M.Sc.
From the Manchester Academic Health Science Center and Mental Health and Neurodegeneration Research Group, University of Manchester, Manchester, United Kingdom; the Mental Health and Social Care Trust, Manchester, United Kingdom; the Vascular Studies Unit and Academic Surgery Unit, University of Manchester, Manchester, United Kingdom; and the Department of Medical Statistics, University Hospital of South Manchester, Manchester, United Kingdom.
Ewan P. Perry, Ph.D.
From the Manchester Academic Health Science Center and Mental Health and Neurodegeneration Research Group, University of Manchester, Manchester, United Kingdom; the Mental Health and Social Care Trust, Manchester, United Kingdom; the Vascular Studies Unit and Academic Surgery Unit, University of Manchester, Manchester, United Kingdom; and the Department of Medical Statistics, University Hospital of South Manchester, Manchester, United Kingdom.
Joanne Wren, B.Sc.
From the Manchester Academic Health Science Center and Mental Health and Neurodegeneration Research Group, University of Manchester, Manchester, United Kingdom; the Mental Health and Social Care Trust, Manchester, United Kingdom; the Vascular Studies Unit and Academic Surgery Unit, University of Manchester, Manchester, United Kingdom; and the Department of Medical Statistics, University Hospital of South Manchester, Manchester, United Kingdom.
Charles McCollum, M.D., F.R.C.S.
From the Manchester Academic Health Science Center and Mental Health and Neurodegeneration Research Group, University of Manchester, Manchester, United Kingdom; the Mental Health and Social Care Trust, Manchester, United Kingdom; the Vascular Studies Unit and Academic Surgery Unit, University of Manchester, Manchester, United Kingdom; and the Department of Medical Statistics, University Hospital of South Manchester, Manchester, United Kingdom.

Notes

Address correspondence to Dr. Purandare ([email protected]).

Funding Information

The authors report no financial relationships with commercial interests.Supported by the Alzheimer's Society (United Kingdom), a registered charity, which had no involvement in the study design or the collection, analysis, or interpretation of the data or in the writing of the present article or the decision to submit it for publication.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share